Filing Flows › Nuvation Bio (NUVB) › Who owns the stock
Who owns Nuvation Bio (NUVB) stock
228 funds reported Nuvation Bio (NUVB) shares in their latest 13F filings, worth $1.5B in all. The largest holder is FMR LLC ($297M). Last quarter 135 funds added to their stakes and 68 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| FMR LLC | 52,230,295 | $297M | increase | 2026-06-30 |
| BlackRock | 27,630,837 | $157M | increase | 2026-06-30 |
| Decheng Capital LLC | 25,954,439 | $147M | unchanged | 2026-06-30 |
| Vanguard Group | 15,555,606 | $139M | increase | 2025-12-31 |
| Vanguard Capital Management LLC | 11,919,514 | $67.7M | increase | 2026-06-30 |
| Omega Fund Management, LLC | 8,081,089 | $45.9M | unchanged | 2026-06-30 |
| Laurion Capital Management LP | 7,697,272 | $43.1M | decrease | 2026-09-30 |
| State Street | 7,370,794 | $41.9M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 6,244,805 | $35.5M | increase | 2026-06-30 |
| Duquesne Family Office LLC | 4,539,800 | $25.8M | unchanged | 2026-06-30 |
| American Century Companies | 4,499,643 | $25.6M | increase | 2026-06-30 |
| Bank of America | 3,529,748 | $20.0M | increase | 2026-06-30 |
| Tang Capital Management LLC | 3,299,557 | $18.7M | increase | 2026-06-30 |
| Redmile Group, LLC | 3,031,009 | $17.2M | decrease | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2,688,666 | $15.3M | increase | 2026-06-30 |
Nuvation Bio's latest quarter
Nuvation Bio, Q3 2026: revenue $45.0M (+243% year over year), operating margin -93.9%, net loss $41.9M, operating cash flow −$38.6M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most NUVB stock?
By the latest 13F filings: FMR LLC ($297M); BlackRock ($157M); Decheng Capital LLC ($147M); Vanguard Group ($139M); Vanguard Capital Management LLC ($67.7M).
What is the short interest in NUVB?
63,220,203 shares were sold short at the 2026-10-15 settlement, 7.4% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.